DEEPEXI TECH to Raise HK$401.70 Million Through 7.94 Million H-Share Placement at 19.78% Discount

Bulletin Express
05/21

DEEPEXI Technology Co., Ltd. (DEEPEXI TECH) has entered into a placing agreement with CLSA Limited (sole overall coordinator) and four other placing agents to issue 7.94 million new H shares under its existing 20% general mandate.

The new shares will be offered at HK$50.58 each, representing a 19.78% discount to the 20 May 2026 closing price of HK$63.05 and a 19.60% discount to the five-day average of HK$62.91. The placement represents 2.431% of the current issued share capital and 2.374% of the enlarged share base.

Gross proceeds are expected to reach HK$401.70 million, with net proceeds estimated at HK$395.00 million, implying a net issue price of HK$49.73 per share. Allocation of the funds is planned as follows: • 70% for overseas market expansion and localisation, including new regional offices, marketing initiatives, and enhancement of service and delivery capabilities. • 20% for strategic investments and acquisitions that align with DEEPEXI TECH’s core business and international growth strategy. • 10% for working capital and general corporate purposes.

Completion is contingent on conditions such as Hong Kong Stock Exchange listing approval and absence of any material adverse change before closing, which is expected no later than 29 May 2026. The company has agreed to a 45-day lock-up period on further equity issuance, excluding the current placement.

Post-placement, total issued shares will rise from 326.63 million to 334.57 million. Public float will remain above the required 15%, with placees collectively holding approximately 2.37% of the enlarged share capital.

No other shares have been issued under the current general mandate. DEEPEXI TECH last raised equity in October 2025, securing HK$657.28 million in net proceeds from its Hong Kong listing.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10